study question: Does the quality of a single transferred embryo have an effect on the pregnancy outcome? summary answer: After adjusting for confounding maternal variables, poor embryo quality was not associated with adverse obstetric or perinatal outcome in this small pilot study.
Introduction
Embryo quality, based on morphological parameters, is a major predictor for the success of in vitro fertilization treatment and the association between the quality of cleavage embryos and the implantation rate and pregnancy outcome has been well established (Giorgetti et al., 1995; Ziebe et al., 1997; Van Royen et al., 1999) . There is a particularly strong association between blastocyst morphology and the rates of implantation, clinical pregnancy and live birth. However, which of the three morphological characteristics of the blastocyst predicts implantation and live birth remains unclear. Various reports suggest blastocele expansion and hatching (Balaban et al., 2000; Van den Abbeel et al., 2013) , the appearance of inner cell mass (ICM) (Richter et al., 2001) or the trophectoderm cells (Ahlstrom et al., 2011; Hill et al., 2013) as the strongest predicting factors.
It is known that singletons conceived by in vitro fertilization are at an increased risk of adverse pregnancy outcome including low birthweight, preterm delivery (PTD) and pre-eclampsia (Olivennes et al., 1993; Jackson et al., 2004; Romundstad et al., 2006; Reddy et al., 2007; McDonald et al., 2009; Cooper et al., 2011 , Pinborg et al., 2013 . Whether those outcomes are related to the infertility itself, the IVF technology or the embryo quality is uncertain (Hayashi et al., 2012) . Improved obstetric and perinatal outcomes from pregnancies resulting from frozen thawed embryos could be partially explained by the transfer of a good quality embryo (Pelkonen et al., 2010; Maheshwari et al., 2012) .
To the best of our knowledge there have been no studies evaluating the possible effect of embryo quality on the pregnancy outcome in pregnancies resulting from fresh single embryo transfers (SET). The purpose of our study was to compare the outcomes of singleton pregnancies resulting from the transfer of a single fresh good quality embryo with those resulting from the transfer of a single fresh poor quality embryo in women ,40 years old, after adjusting for confounding variables.
Materials and Methods

Patients, stimulation protocol, IVF and embryo culture
We performed a retrospective cohort study evaluating the outcome of SET performed between December 2008 (the beginning of electronic medical records at the clinic) and December 2012, at the reproductive unit of the McGill University Health Center (MUHC) in Montreal. Only women ,40 years who underwent their first fresh SET using non-donor oocytes were included. Women were included in the study only once. The Research and Ethics Board of MUHC approved the study (MUHC Study code 12-283-SDR).
Following our standard practice, pregnancy outcome and placental pathology reports of the patients are continuously updated in the McGill Obstetric and Neonatal database. We obtained any missing information by detailed telephone surveys conducted by trained personnel at our center.
We compared cycle outcomes and singleton live births resulting from transfer of a single fresh good quality (Grade 2) embryo with those resulting from the transfer of a single fresh poor quality (fair, Grade 3 or poor, Grade 4) embryo in the cleavage or blastocyst stages. Fair quality (Grade 3) embryos were grouped together with poor quality (Grade 4) embryos for statistical purposes.
Only 12 cases of SET occurred prior to August 2010. The practice of SET at our clinic was facilitated by the change in the Quebec policy for public funding of assisted reproductive technology in August 2010 when SET became the rule, apart for exceptional cases.
We used one of four protocols: a microdose flare protocol (initiation of GnRH agonist on Days 2 -3 of the cycle after oral contraceptive induced withdrawal bleeding and gonadotrophin on the third day of the GnRH agonist), a fixed antagonist protocol (gonadotrophin on Days 2 -3 of the cycle and GnRH antagonist on the sixth day of stimulation), a mid-luteal long agonist protocol (GnRH agonist in the mid-luteal phase and gonadotrophin after 2 weeks of down-regulation) or a natural cycle IVF with no gonadotrophin stimulation.
Causes of infertility included polycystic ovarian syndrome (PCOS), male infertility, tubal factor infertility, endometriosis (diagnosis by laparoscopy or ultrasound diagnosis of ovarian endometrioma), poor ovarian reserve (Ferraretti et al., 2011) or unexplained infertility.
Based on semen quality on the day of oocyte retrieval, the oocytes were inseminated 3 -6 h after oocyte retrieval with either ICSI or conventional insemination. Fertilization was indicated by the appearance of two distinct pronuclei and two polar bodies 16 -18 h after insemination. The zygotes were cultured in cleavage medium (COOK Medical, Sidney, Australia). Embryonic development was assessed on Day 2 (41 -43 h) and on Day 3 (65-67 h) after insemination. Blastocysts were cultured in the cleavage medium for the first 72 h and subsequently in the blastocyst medium (COOK Medical) until Days 5 -6. Fresh cleavage embryo transfer was performed using embryos with the highest number of blastomeres with the highest embryo score.
If necessary, assisted hatching with laser zona drilling (20 mm) was performed in embryos selected for embryo transfer. This was done under an inverted microscope in a microdrop (40 ml) using a ZILOS-tkZona Infrared Laser Optical System (version 3.29, Hamilton Thorne Instruments Biosciences, Beverly, MA, USA). Assisted hatching was performed for the following cases: women with an elevated Day 3 FSH (≥15 mIU/ml), embryos with a zona pellucida thicker than 15 mm, or cleavage embryos with ,5 cells 68 -72 h after collection or over 20% fragmentation in the perivitelline space.
The day of embryo transfer was determined based on the quantity and quality of embryos either on Day 2, 3 (cleavage embryos) or 5 (blastocysts). Embryo transfer was performed under ultrasound guidance and a serum beta-hCG pregnancy test was performed 16 days after collection.
Embryo quality
Cleavage embryos were defined as good quality (Grade 2) if they had 4 cells on Day 2 and/or 7 or 8 cells on Day 3, contained ,20% anucleate fragments, and exhibited no apparent morphological abnormalities. Poor quality embryos included fair quality (Grade 3) embryos, with only 2 cells on Day 2, 3 -5 cells on Day 3 and/or 20 -50% fragmentation and poor quality (Grade 4) embryos which were those with ,3 cells by Day 3 and .50% fragmentation (Reinblatt et al., 2011) . On Day 5, embryos were scored for blastocyst formation. Blastocysts were graded according to the size of the blastocyst, the assessment of the ICM and trophectoderm development [≥3BB] (Gardner et al., 2004) . Good quality embryos (Grade 2) were defined as those where at least: [3] the blastocele completely fills the embryo, [B] the ICM is loosely grouped with several cells and [B] the trophoectoderm has very few cells forming a loose epithelium. Lower than 3BB quality embryos on Day 5 were defined as poor quality embryos (Grade 3 or 4). The allocation to blastocyst versus cleavage transfer was based on the age of the patient and the number and quality of cleavage embryos available.
Blastocyst grading was performed by two trained embryologists, each with over 10 years of experience. After embryo transfer, excess blastocysts of 3BB or higher were frozen using the vitrification method. Embryo transfer was defined 'elective' when there were more than one high-quality embryos Embryo quality and pregnancy outcome after SET available but only one embryo was transferred mainly due to government policy (Practice committee, 2012).
Clinical outcome
Cycle outcome was evaluated as biochemical or clinical pregnancies, with the latter including miscarriage, stillbirth and live births. We also assessed neonatal and maternal pregnancy complications. Adverse neonatal outcomes included small for gestational age (SGA) (defined as birthweight below the 10th percentile for gestational age using the Canadian population-based live born infant birthweight curves) (Kramer et al., 2001) , low birthweight (LBW) (,2500 g), very low birthweight (VLBW) (,1500 g), large for gestational age (LGA) (birthweight above 90th percentile), PTD delivery ,37 weeks of gestation and early PTD , 32 weeks of gestation, hospitalization in the neonatal intensive care unit, respiratory or gastrointestinal complications and congenital malformations. 
Statistical analysis
Statistical analysis was performed using SAS 9.2. Patient characteristics and clinical outcomes were tabulated by grade. x 2 or Fisher's exact test was performed for categorical variables and Wilcoxon rank sum tests for continuous variables. The association between embryo quality and a specific clinical outcome was assessed using multivariable logistic analysis. We adjusted for confounders including maternal age, body mass index (BMI), smoking, cause of infertility, parity and gender of the baby. A subanalysis was performed for the live births divided by transfer day. A P value of ,0.5 was considered statistically significant.
Results
Demographic and treatment characteristics of the single embryo transfer groups
Of a total of 1541 fresh IVF-SET cycles using non-donor oocytes, there were 1193 transfers of a single good quality embryo and 348 transfers of a single poor quality embryo, resulting in 563 pregnancies and 440 singleton births. Eight monozygotic twins resulting from single good quality embryo transfers were excluded from the analysis. Patient demography and treatment characteristics are presented in Table I . The mean maternal age was 6 months higher, there were less elective embryo transfers, more cleavage embryo transfers and more assisted hatching performed in the poor quality embryo transfer group (P , 0.001). The groups differed in treatment characteristics with an increased gonadotrophin dose, and a reduced number of mature and fertilized oocytes in the poor quality embryo transfer group. Table II summarizes the cycle outcome resulting from the transfer of a single good or poor quality embryo. The transfer of a good quality embryo was associated with a 2-fold increased chance of a clinical pregnancy and a live birth. The biochemical pregnancy rate was 13.8% (80/ 576) and 14.1% (11/78) in the good and poor quality embryo transfer groups, respectively (P ¼ 0.96). Demographic and obstetric outcome of the live birth groups resulting from the transfer of a single good or poor quality embryo There were significantly more blastocyst stage transfers amongst the live births from the transfer of a single good quality embryo. There were no differences in mean birthweight, gestational age, growth restriction or PTD between the two groups. After adjustment for known risk factors including maternal age, BMI, smoking, parity and gender of the baby, there were still no differences in obstetric or perinatal outcomes between the groups (Table IV) . A subanalysis of causes of infertility and pregnancy outcome yielded a significantly higher adverse rate of maternal complications in the patients with poor ovarian reserve 5/22 (22.7%) compared other causes of infertility 32/418 (7.6%) (P ¼ 0.018). The distribution of other pregnancy complications or neonatal complications was similar between the groups.
Demographic and obstetric outcome of the live birth groups resulting from the transfer of a single good or poor quality embryo stratified by day of transfer Table V shows that the maternal characteristics and the pregnancy outcomes including obstetric and perinatal complications are similar in all four live birth groups resulting from the transfer of a single good quality blastocyst, a single good quality cleavage embryo, a poor quality blastocyst and a poor quality cleavage embryo.
Discussion
The aim of our study was to assess obstetric and perinatal risks associated with embryo quality. The hypothesis that embryo quality may have an effect on pregnancy outcome stems from reports that female factor infertility itself may be implicated in increased perinatal risks (including PTD, low birthweight, pre-eclampsia and placental abruption) (McElrath et al., 1997; Jackson et al., 2004; Wang et al., 2005 , McDonald et al., 2009 . Supporting this contention, we found that poor ovarian reserve was associated with increased adverse maternal complications.
However, the results of our small sample study showed that pregnancies resulting from the transfer of a poor quality embryo were comparable to those from the transfer of a good quality embryo and were not associated with increased adverse obstetric and perinatal outcomes. These findings remained after adjusting for maternal confounding variables and after stratifying according to the day of transfer. It is important to note however that the lack of statistical differences could be merely due to the small number of cases in the study.
Previous studies evaluating a possible effect of embryo quality on perinatal outcome have been done using fresh and frozen cycles. Some studies demonstrated that pregnancies resulting from frozen embryo transfers were associated with less adverse outcomes compared with those resulting from fresh embryo transfers (Pelkonen et al., 2010; Maheshwari et al., 2012) . Others could not confirm this finding (Sazonova et al., 2012) . A possible explanation for a better perinatal outcome with frozen embryos is a lower degree of asynchrony between the phase of embryo development and the endometrial receptivity in frozen unstimulated cycles. Another explanation could be the natural selection of good quality embryos with thawing after cryopreservation, attributing the improved perinatal outcome to embryo quality. We did not find improved perinatal outcomes with better quality embryos, neither did we find poorer pregnancy outcomes with the transfer of poor quality embryos.
Although this study was not aimed to assess whether embryo quality is related to pregnancy rates, the results of our study show that the clinical pregnancy and live birth rates per transfer were nearly 2-fold higher with the transfer of a single good quality embryo than with the transfer of a poor quality embryo (41.5 and 32.3% versus 19.2 and 15.5%, respectively). The increased in pregnancy and live birth rates could be attributed in part to the lower maternal age, the higher number of mature and fertilized oocytes, the higher rate of elective transfers and more cases of culture to the blastocyst stage in this group. Embryo quality and pregnancy outcome after SET previous studies showing a strong association between embryo quality and implantation and live birth rates, both with cleavage and blastocyst embryos (Giorgetti et al.,1995; Ziebe et al., 1997; Van Royen et al., 1999; Balaban et al., 2000; Richter et al., 2001; Ahlstrom et al., 2011; Hill et al., 2013; Van den Abbeel et al., 2013) . To date, there have been three studies with fresh single blastocyst transfers that have shown a strong association between expansion and trophectoderm cell morphology with implantation and live birth rates. They showed a 2-fold higher proportion of live births from the implantation of good quality embryos (40 -50%) compared with that from poor quality embryos (10 -20 %) (Ahlstrom et al., 2011; Hill et al., 2013; Van den Abbeel et al., 2013) .
Our findings may be used to reassure women that although the chance of a clinical pregnancy with a single poor quality embryo is lower than that Data are presented as mean + SD and proportion (%). Excluding eight sets of monozygotic twins all from good quality embryo transfers. BMI, body mass index at the start of infertility treatment. NVD, normal vaginal delivery; C/S, Cesarean section. Primary infertility (gravidity ¼ 0). SGA, small for gestational age (,10%); LBW, low birthweight (,2500 g); VLBW, very low birthweight (,1500 g); PTD, preterm delivery (,37 weeks); Early PTD (,32 weeks), LGA, large for gestational age (.90%).
of a good quality embryo, once a clinical pregnancy is achieved it has a similar chance of reaching a live birth as a good quality embryo (77.8 and 80.6%, respectively).
A recent meta-analysis summarizing obstetric and perinatal outcomes of singletons from transfers of one or more blastocyst and cleavage embryos reported an increased risk of PTD with extended culture, Data are presented as mean + SD and proportion (%). Excluding eight sets of monozygotic twins all from good quality embryo transfers. Primary infertility (gravidity ¼ 0).
Embryo quality and pregnancy outcome after SET with no increased incidence of SGA or LBW (Maheshwari et al., 2013) . Therefore due to a possible effect of day of transfer on the pregnancy outcome, we further analyzed the data and stratified according to the day of transfer. No differences in pregnancy outcomes were observed between the transfer day and embryo quality groups, although the sample size in some of the groups was too small to reach any definite conclusion.
A major strength of our study is that this study included only SETs. It eliminated the possibility of vanishing twin phenomenon that could be as high as 10% of double embryo transfers that result in a singleton live birth (Poikkeus et al., 2007) . Another strength is that this was a single center study where embryos were assessed by the same trained embryologists, reducing the intra-observer variability of grading. The embryos were also cultured in the same media, eliminating the possible effects of various culture media on the subsequent neonatal birthweights (Dumoulin et al., 2010 , Vergouw et al., 2012 .
Our results are limited by the relatively small numbers of live births resulting from poor quality embryos. On the other hand, single poor quality embryo transfers are not common. In cycles with a single poor quality embryo, the transfer is either cancelled or the embryo is transferred together with a good quality embryo without knowing which embryo will eventually implant. Since our program is publicly funded with a SET rule and a very low cancellation rate (,2%), we believe this is a unique opportunity to evaluate pregnancies resulting from single poor quality embryo transfers (Tulandi et al., 2013) .
In addition, our findings are limited by the retrospective design of the study. The transfer day was based on the age of the patient and the number and quality of cleavage embryos available and could be a confounding variable. Furthermore, we did not have data on potential confounders such as ethnicity, prior obstetric complications and family history, and there was a relatively small number of deliveries resulting from the transfer of poor quality embryos. There were only 12 cases of SETs prior to August 2010, and our policy after this time to transfer a single embryo was affected by the patient's age, fertility history and embryo quality in exceptional cases. While the implantation and clinical pregnancy rates might have been affected by including elective and non-elective SETs, it is unlikely to influence the pregnancy outcome including maternal and neonatal complications.
We conclude that in our small pilot study, pregnancies resulting from the transfer of a single fresh poor quality embryo, whether at the cleavage or blastocyst stage, did not result in any obvious increased risk of adverse obstetric or perinatal outcomes compared with those from the transfer of a good quality embryo. If validated in larger studies, this information could be important to reassure couples who conceive following the transfer of poor quality embryos.
